全文获取类型
收费全文 | 1459篇 |
免费 | 100篇 |
国内免费 | 81篇 |
专业分类
耳鼻咽喉 | 1篇 |
儿科学 | 75篇 |
妇产科学 | 9篇 |
基础医学 | 215篇 |
口腔科学 | 23篇 |
临床医学 | 231篇 |
内科学 | 330篇 |
皮肤病学 | 33篇 |
神经病学 | 29篇 |
特种医学 | 306篇 |
外科学 | 102篇 |
综合类 | 38篇 |
预防医学 | 36篇 |
眼科学 | 7篇 |
药学 | 83篇 |
肿瘤学 | 122篇 |
出版年
2022年 | 6篇 |
2021年 | 10篇 |
2019年 | 11篇 |
2018年 | 7篇 |
2017年 | 9篇 |
2016年 | 10篇 |
2015年 | 19篇 |
2014年 | 12篇 |
2013年 | 27篇 |
2012年 | 16篇 |
2011年 | 17篇 |
2010年 | 56篇 |
2009年 | 46篇 |
2008年 | 22篇 |
2007年 | 64篇 |
2006年 | 29篇 |
2005年 | 35篇 |
2004年 | 17篇 |
2003年 | 22篇 |
2002年 | 28篇 |
2001年 | 23篇 |
2000年 | 26篇 |
1999年 | 24篇 |
1998年 | 103篇 |
1997年 | 91篇 |
1996年 | 116篇 |
1995年 | 88篇 |
1994年 | 92篇 |
1993年 | 77篇 |
1992年 | 33篇 |
1991年 | 41篇 |
1990年 | 40篇 |
1989年 | 42篇 |
1988年 | 43篇 |
1987年 | 35篇 |
1986年 | 39篇 |
1985年 | 40篇 |
1984年 | 18篇 |
1983年 | 28篇 |
1982年 | 29篇 |
1981年 | 24篇 |
1980年 | 19篇 |
1979年 | 11篇 |
1978年 | 11篇 |
1977年 | 24篇 |
1976年 | 16篇 |
1975年 | 11篇 |
1974年 | 11篇 |
1970年 | 3篇 |
1969年 | 5篇 |
排序方式: 共有1640条查询结果,搜索用时 0 毫秒
1.
2.
3.
Potential aripiprazole-mediated extrapyramidal symptoms in an adult with developmental disabilities.
Nancy C Brahm David L McElwain Robert C Brown 《American journal of health-system pharmacy》2007,64(8):827-829
PURPOSE: A case of extrapyramidal symptoms (EPS) following administration of aripiprazole to a man with developmental disabilities who had never received antipsychotic medications and had no history of movement disorders is presented. SUMMARY: The patient was a 40-year-old male with developmental disabilities. He was nonverbal, profoundly mentally retarded, and diagnosed with obsessive compulsive disorder (OCD) and orthopedic problems. He developed episodic movements possibly consistent with EPS secondary to aripiprazole usage. The patient was antipsychotic naive before initiation of aripiprazole 5 mg daily. Concurrent medications at the time of EPS onset included oxazepam, baclofen, and citalopram. Baclofen and oxazepam were prescribed secondary to right-sided hemiparesis contractures. Aripiprazole, 5 mg daily, was initiated in November 2004 as an augmentation strategy for the diagnosis of OCD. Facial, tongue, and arm movements were first reported approximately five weeks after the initiation of aripiprazole. Initial symptoms resolved after approximately 24 hours. The dosage was increased to 10 mg daily two weeks later. Dystonic episodes continued on an intermittent basis, and the patient presented with lower-lip thrusting and upper-limb athetosis. These movements interfered with the patient's eating, chewing, and holding of utensils. Several of the standard treatment strategies for EPS were used. Initially, diphenhydramine hydrochloride 25 mg was administered orally every six hours. The patient's movements resolved following diphenhydramine administration. Aripiprazole was subsequently discontinued secondary to its lack of efficacy for OCD and the development of a movement disorder. CONCLUSION: A patient with developmental disabilities who had no history of movement disorders developed EPS following initiation of aripiprazole. 相似文献
4.
5.
6.
7.
8.
9.
Y Leskinen JP Salenius T Lehtim?ki H Huhtala H Saha 《American journal of kidney diseases》2002,40(3):472-479
BACKGROUND: Knowledge of the prevalence of peripheral arterial disease (PAD) in patients with chronic renal failure (CRF) is limited because of a lack of uniformity in disease definition and recognition. Furthermore, little is known of the prevalence of medial arterial calcification (MAC) in patients with CRF. Our goal is to study the prevalence of PAD and MAC defined by ankle brachial index (ABI) or toe brachial index (TBI) measurements in a Finnish population of patients with CRF consisting of predialysis and dialysis patients, as well as renal transplant recipients. METHODS: We examined 136 patients with CRF and 59 control subjects. Fifty-nine of the patients with CRF had moderate to severe predialysis CRF, 36 patients were on dialysis treatment, and 41 were renal transplant recipients. Mean age of patients was 51.9 +/- 11.5 years, and 39 patients (29%) had diabetes. ABI and TBI were measured by means of photoplethysmography. The definition of PAD required an ABI value of 0.90 or less, a TBI value of 0.60 or less, or a previous positive lower-extremity angiogram result. ABI values of 1.3 or greater or incompressible arteries at ankle level indicated MAC. The presence of claudication was determined by an interview. RESULTS: Prevalences of PAD on this study were 22.0% in patients with predialysis CRF, 30.6% in patients on dialysis treatment, 14.6% in renal transplant recipients, and 1.7% in the control group (P = 0.001). Prevalences of MAC were 23.7%, 41.7%, 23.1%, and 3.4% (P < 0.001), respectively. Only 9 patients had claudication, and 6 of those patients had PAD. CONCLUSION: Both asymptomatic PAD and MAC are common in patients with CRF. Therefore, we recommend the use of both ABI and TBI measurements in the evaluation of PAD in patients with CRF. 相似文献
10.
C R Pinkerton J Groot-Loonen A Barrett S T Meller D Tait S Ashley T J McElwain 《British journal of cancer》1991,64(2):381-385
Forty-three children with malignant soft tissue sarcomas (IRS Groups II-IV) were treated with rapid dose delivery chemotherapy protocol comprising six courses of vincristine, adriamycin and cyclophosphamide, given in most cases within 8 weeks (Rapid VAC). This was followed in 36 patients by high dose melphalan with autologous bone marrow rescue. Twenty-six patients also received irradiation to the site of primary tumour. The Rapid VAC regimen was well tolerated and largely administered as an out-patient. There was one toxic death which occurred 2 months after high dose melphalan due to a combination of infection and possible anthracycline cardiomyopathy. Stages were, (Intergroup Rhabdomyosarcoma Study (IRS) system) Group, Group II--four patients. Group III--27 patients and Group IV--12 patients; International Society of Paediatric Oncology (SIOP) staging, Stage I--11, Stage II--13, Stage III--7, Stage IV--12. Actuarial survival at 5 years for all stages is 57% and event free survival 44%. For patients with non-metastatic diseases, 62% and 53% respectively. This treatment strategy utilises the philosophy of rapid drug delivery with high dose consolidation and enables all chemotherapy to be finished within a 4 month period. In general, a conservative approach was applied to both radiation and surgery to minimise late sequelae related to these treatment modalities. Although the small number of high risk patients in this study limits conclusions regarding efficacy in these subgroups the overall results with this regimen appear to be comparable to that with other approaches. 相似文献